{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:05:34Z","timestamp":1790813134465,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbr.2025.115465","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T11:57:39Z","timestamp":1738843059000},"page":"115465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Neuroinflammation in kidney disease and dialysis"],"prefix":"10.1016","volume":"483","author":[{"given":"Yumi Watanabe","family":"Chagas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Alves S.","family":"Vaz de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Sim\u00f5es-e-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2025.115465_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.bbr.2025.115465_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0002-9343(98)00245-9","article-title":"Psychiatric illness in patients with end-stage renal disease","volume":"105","author":"Kimmel","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib3","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00467-015-3159-6","article-title":"Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease","volume":"30","author":"Moreira","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1042\/CS20160927","article-title":"Kidney-brain axis inflammatory cross-talk: from bench to bedside","volume":"131","author":"Miranda","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbr.2025.115465_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40473-020-00207-4","article-title":"Inflammatory pathways in psychiatric disorders: the case of schizophrenia and depression","volume":"7","author":"Feng","year":"2020","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.bbr.2025.115465_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.bbr.2025.115465_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-015-0423-4","article-title":"Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL\/lpr mice","volume":"12","author":"Stock","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2025.115465_bib8","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2174\/0929867325666180226102358","article-title":"RAS in the central nervous system: potential role in neuropsychiatric disorders","volume":"25","author":"Rocha","year":"2018","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.bbr.2025.115465_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.wnl.0000225182.15532.40","article-title":"Cognitive impairment in hemodialysis patients is common","volume":"67","author":"Murray","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2025.115465_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/1980-57642016dn11-030003","article-title":"Cognitive impairment of patients with chronic renal disease on hemodialysis and its relationship with sociodemographic and clinical characteristics","volume":"11","author":"Gesualdo","year":"2017","journal-title":"Dement. Neuropsychol."},{"key":"10.1016\/j.bbr.2025.115465_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.719208","article-title":"Cognitive impairment early after initiating maintenance hemodialysis: a cross sectional study","volume":"13","author":"Schorr","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.bbr.2025.115465_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5935\/0101-2800.20140035","article-title":"Cognitive alterations in chronic kidney disease: an update","volume":"36","author":"da Matta","year":"2014","journal-title":"J. Bras. Nefrol."},{"key":"10.1016\/j.bbr.2025.115465_bib13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2215\/CJN.14191218","article-title":"Psychiatric Illness and Mortality in Hospitalized ESKD Dialysis Patients","volume":"14","author":"Kimmel","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00467-006-0298-9","article-title":"Psychiatric disorders in children with chronic renal failure","volume":"22","author":"Bakr","year":"2007","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib15","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/01.ASN.0000131529.60019.FA","article-title":"Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study","volume":"15","author":"Seliger","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ncl.2009.09.003","article-title":"Neurologic presentations of renal diseases","volume":"28","author":"Lacerda","year":"2010","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbr.2025.115465_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cca.2019.10.038","article-title":"Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson\u2019s disease","volume":"501","author":"Sankowski","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbr.2025.115465_bib18","first-page":"51","article-title":"Comparison of mental health, quality of sleep and life among patients with different stages of chronic kidney disease and undergoing different renal replacement therapies","volume":"24","author":"K\u00fc\u00e7\u00fck","year":"2020","journal-title":"Hippokratia"},{"key":"10.1016\/j.bbr.2025.115465_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/ipj.ipj_23_19","article-title":"A comparative study of psychosocial determinants and mental well-being in chronic kidney disease patients: a closer look","volume":"28","author":"Khan","year":"2019","journal-title":"Ind. Psychiatry J."},{"key":"10.1016\/j.bbr.2025.115465_bib20","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2215\/CJN.09751110","article-title":"Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease","volume":"6","author":"Hooper","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/DBP.0000000000000267","article-title":"Neurocognitive, social-behavioral, and adaptive functioning in preschool children with mild to moderate kidney disease","volume":"37","author":"Hooper","year":"2016","journal-title":"J. Dev. Behav. Pedia"},{"key":"10.1016\/j.bbr.2025.115465_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/DBP.0000000000000221","article-title":"Executive functioning in children, adolescents, and young adults with chronic kidney disease","volume":"36","author":"Hooper","year":"2015","journal-title":"J. Dev. Behav. Pedia"},{"key":"10.1016\/j.bbr.2025.115465_bib23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.ajkd.2011.05.027","article-title":"Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States","volume":"58","author":"Tamura","year":"2011","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00467-016-3425-2","article-title":"Association of blood pressure variability and neurocognition in children with chronic kidney disease","volume":"31","author":"Lande","year":"2016","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2215\/CJN.00810111","article-title":"Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study","volume":"6","author":"Lande","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/STROKEAHA.107.493494","article-title":"Kidney function is related to cerebral small vessel disease","volume":"39","author":"Ikram","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2025.115465_bib27","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/STROKEAHA.107.493593","article-title":"Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS)","volume":"38","author":"Khatri","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2025.115465_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1148\/radiol.2018171339","article-title":"Regional cerebral blood flow in children and young adults with chronic kidney disease","volume":"288","author":"Liu","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.bbr.2025.115465_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1681\/ASN.2014111118","article-title":"Kidney function and cerebral blood flow: the rotterdam study","volume":"27","author":"Sedaghat","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0006-8993(92)90200-S","article-title":"The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice","volume":"598","author":"D\u2019Hooge","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2025.115465_bib31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0378-4274(92)90261-H","article-title":"Behavioral toxicity of guanidinosuccinic acid in adult and young mice","volume":"64-65","author":"D\u2019Hooge","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbr.2025.115465_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1172\/JCI107984","article-title":"Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes","volume":"55","author":"Guisado","year":"1975","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bbr.2025.115465_bib33","series-title":"Nutritional Management of Renal Disease (Fourth Edition)","first-page":"77","article-title":"Chapter 6 - Uremic toxins: an integrated overview of classification and pathobiology","author":"Glassock","year":"2022"},{"key":"10.1016\/j.bbr.2025.115465_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131707","article-title":"The addition of vascular calcification scores to traditional risk factors improves cardiovascular risk assessment in patients with chronic kidney disease","volume":"10","author":"Liabeuf","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bbr.2025.115465_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2004.07.012","article-title":"Neurological complications in renal failure: a review","volume":"107","author":"Brouns","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbr.2025.115465_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/cn500363g","article-title":"The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives","volume":"6","author":"Kaur","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib37","doi-asserted-by":"crossref","first-page":"16917","DOI":"10.3390\/ijms140816917","article-title":"ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer\u2019s disease","volume":"14","author":"AbdAlla","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbr.2025.115465_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2015.01.005","article-title":"Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension","volume":"124","author":"Rinc\u00f3n","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib40","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1042\/CS20160116","article-title":"Anxiolytic- and antidepressant-like effects of angiotensin-(1\u20137) in hypertensive transgenic (mRen2)27 rats","volume":"130","author":"Almeida-Santos","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular infusion of angiotensin-(1\u20137) ameliorates cognitive impairment and memory dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"53","author":"Uekawa","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjamd.2016.24","article-title":"Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function","volume":"2","author":"Wang","year":"2016","journal-title":"Npj Aging Mech. Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jns.2016.07.031","article-title":"Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson\u2019s disease","volume":"368","author":"Rocha","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.190.9.1197","article-title":"Immune Privilege","volume":"190","author":"Hong","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbr.2025.115465_bib46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib47","series-title":"Psychoneuroimmunology (Fourth Edition)","first-page":"271","article-title":"CHAPTER 13 - Expression and Action of Cytokines in the Brain: Mechanisms and Pathophysiological Implications","author":"Dantzer","year":"2007"},{"key":"10.1016\/j.bbr.2025.115465_bib48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1749-6632.1998.tb09597.x","article-title":"Cytokines and sickness behavior","volume":"840","author":"Dantzer","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092293","article-title":"Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration","volume":"20","author":"Batista","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib51","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1681\/ASN.2019070728","article-title":"Uremic toxic blood-brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction","volume":"31","author":"Bobot","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00370","article-title":"Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia","volume":"8","author":"Adesso","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115465_bib53","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000000000167","article-title":"Blood\u2013brain barrier permeability in ESKD\u2014a proof-of-concept study","volume":"34","author":"Gupta","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib54","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.ekir.2024.07.021","article-title":"Increased blood-brain barrier permeability and cognitive impairment in patients with ESKD","volume":"9","author":"Bobot","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.bbr.2025.115465_bib55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2796.2010.02313.x","article-title":"Blocking interleukin-1\u03b2 in acute and chronic autoinflammatory diseases","volume":"269","author":"Dinarello","year":"2011","journal-title":"J. Intern Med"},{"key":"10.1016\/j.bbr.2025.115465_bib56","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1681\/ASN.2016020177","article-title":"Of inflammasomes and alarmins: IL-1\u03b2 and IL-1\u03b1 in kidney disease","volume":"27","author":"Anders","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib57","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"CRIC Study Investigators, Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib58","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2025.115465_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061606","article-title":"Exploring the link between chronic kidney disease and Alzheimer\u2019s disease: a longitudinal follow-up study using the Korean national health screening cohort","volume":"11","author":"Kwon","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbr.2025.115465_bib61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1186\/s12888-023-05249-y","article-title":"Depression among patients with chronic kidney disease, associated factors, and predictors: a cross-sectional study","volume":"23","author":"Bahall","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bbr.2025.115465_bib62","article-title":"Interleukin-1\u03b2 induces blood\u2013brain barrier disruption by downregulating sonic hedgehog in astrocytes","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2025.115465_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2024.06.028","article-title":"Chronic kidney disease leads to microglial potassium efflux and inflammasome activation in the brain","author":"Zimmermann","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbr.2025.115465_bib64","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-\u03b1 induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2025.115465_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.07.002","article-title":"Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation","volume":"204","author":"Mir","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2025.115465_bib66","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/610813","article-title":"Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF","volume":"2015","author":"Fischer","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbr.2025.115465_bib67","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.144.8.2999","article-title":"Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta","volume":"144","author":"Chung","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbr.2025.115465_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cne.903370403","article-title":"Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system","volume":"337","author":"Breder","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbr.2025.115465_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuint.2013.04.007","article-title":"Microglia are the major source of TNF-\u03b1 and TGF-\u03b21 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide, and vitronectin","volume":"63","author":"Welser-Alves","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2025.115465_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2005.01.015","article-title":"Autocrine activation of microglia by tumor necrosis factor-alpha","volume":"162","author":"Kuno","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2025.115465_bib71","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2025.115465_bib72","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0042-6822(03)00181-8","article-title":"Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120","volume":"312","author":"Wang","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.bbr.2025.115465_bib73","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/neu.2009.1016","article-title":"Tumor necrosis factor alpha enhances glutamatergic transmission onto spinal motoneurons","volume":"27","author":"Han","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbr.2025.115465_bib74","doi-asserted-by":"crossref","first-page":"15879","DOI":"10.1523\/JNEUROSCI.0530-13.2013","article-title":"TNF-\u03b1 downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(A) receptors","volume":"33","author":"Pribiag","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib75","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1523\/JNEUROSCI.23-07-02627.2003","article-title":"Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons","volume":"23","author":"Rao","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib76","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.STR.25.7.1481","article-title":"Tumor necrosis factor-alpha expression in ischemic neurons","volume":"25","author":"Liu","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2025.115465_bib77","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","article-title":"Experimental stroke induces massive, rapid activation of the peripheral immune system","volume":"26","author":"Offner","year":"2006","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbr.2025.115465_bib78","first-page":"419","article-title":"Tumor necrosis factor induces glomerular damage in the rabbit","volume":"134","author":"Bertani","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbr.2025.115465_bib79","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.4049\/jimmunol.142.9.3083","article-title":"Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1","volume":"142","author":"Tomosugi","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbr.2025.115465_bib80","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/16.3.518","article-title":"Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha","volume":"16","author":"Karkar","year":"2001","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.bbr.2025.115465_bib81","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and Progression of CKD: The CRIC Study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib82","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2215\/CJN.10441015","article-title":"Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD","volume":"11","author":"Sun","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib83","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/cphy.c120028","article-title":"Immune and inflammatory role in renal disease","author":"Imig","year":"2013","journal-title":"Compr. Physiol. 3"},{"key":"10.1016\/j.bbr.2025.115465_bib84","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","article-title":"Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbr.2025.115465_bib85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3109\/00365513.2011.598944","article-title":"The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy","volume":"71","author":"Taslipinar","year":"2011","journal-title":"Scand. J. Clin. Lab Invest"},{"key":"10.1016\/j.bbr.2025.115465_bib86","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"Su","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2025.115465_bib87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jcmm.13314","article-title":"The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure","volume":"22","author":"Lei","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/1744666X.2022.2045952","article-title":"Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives","volume":"18","author":"Kreiner","year":"2022","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.bbr.2025.115465_bib89","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1194\/jlr.RA119000479","article-title":"Interleukin 6 reduces allopregnanolone synthesis in the brain and contributes to age-related cognitive decline in mice","volume":"61","author":"Parks","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbr.2025.115465_bib90","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbi.2023.06.027","article-title":"Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers \u2013 in cognitively unimpaired older adults","volume":"113","author":"Capogna","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2025.115465_bib91","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1523\/JNEUROSCI.19-11-04305.1999","article-title":"Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice","volume":"19","author":"Zhong","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112993","article-title":"Effect of renal ischemia reperfusion on brain neuroinflammation","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbr.2025.115465_bib93","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00018-013-1459-1","article-title":"Monocyte chemoattractant protein-1 and blood-brain barrier","volume":"71","author":"Yao","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073485","article-title":"The role of CCL2\/CCR2 axis in cerebral ischemia-reperfusion injury and treatment: from animal experiments to clinical trials","volume":"23","author":"Geng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib95","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1242\/jcs.00755","article-title":"Potential role of MCP-1 in endothelial cell tight junction \u201copening\u201d: signaling via Rho and Rho kinase","volume":"116","author":"Stamatovic","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbr.2025.115465_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1445-5994.2011.02538.x","article-title":"Monocyte chemoattractant protein-1 is associated with silent cerebral infarction in patients on haemodialysis","volume":"42","author":"Uchida","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.bbr.2025.115465_bib97","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-023-02703-2","article-title":"Chronic kidney disease promotes cerebral microhemorrhage formation","volume":"20","author":"Fang","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2025.115465_bib98","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","article-title":"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature","volume":"21","author":"Stanford","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib99","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","article-title":"Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism","volume":"33","author":"Lambert","year":"2023","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.bbr.2025.115465_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.579386","article-title":"The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses","volume":"11","author":"Luo","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.bbr.2025.115465_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.787370","article-title":"Is it removed during dialysis?\u201d\u2014Cognitive dysfunction in advanced kidney failure\u2014a review article","volume":"12","author":"Crowe","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbr.2025.115465_bib102","unstructured":"G.E. Schreiner, J.F. Maher, Uremia: Biochemistry, pathogenesis and treatment, Thomas, 1961."},{"key":"10.1016\/j.bbr.2025.115465_bib103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00002480-197201000-00064","article-title":"Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis","volume":"18","author":"Alfrey","year":"1972","journal-title":"Trans. Am. Soc. Artif. Intern Organs"},{"key":"10.1016\/j.bbr.2025.115465_bib104","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/bmj.1.6120.1101","article-title":"Aluminium toxicity during regular haemodialysis","volume":"1","author":"Elliott","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbr.2025.115465_bib105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ackd.2008.01.010","article-title":"Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden","volume":"15","author":"Murray","year":"2008","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib106","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1053\/j.ajkd.2014.02.012","article-title":"Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis","volume":"64","author":"Costa","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib107","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.kint.2016.11.015","article-title":"CRIC Study Investigators, Loss of executive function after dialysis initiation in adults with chronic kidney disease","volume":"91","author":"Kurella Tamura","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbr.2025.115465_bib108","first-page":"89","article-title":"Cognitive function and advanced kidney disease: longitudinal trends and impact on decision-making","volume":"10","author":"Iyasere","year":"2017","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.bbr.2025.115465_bib109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1681\/ASN.2018050462","article-title":"Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients","volume":"30","author":"Findlay","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib110","article-title":"Effect of a hemodialysis session on markers of inflammation and endotoxin","volume":"2022","author":"Dheda","year":"2022","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.bbr.2025.115465_bib111","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1053\/ajkd.2001.29280","article-title":"Oxidative stress and inflammation in hemodialysis patients","volume":"38","author":"Spittle","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib112","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0272-6386(03)00653-X","article-title":"Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy","volume":"42","author":"Danielski","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib113","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/ajkd.2002.36334","article-title":"Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation","volume":"40","author":"Tovbin","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib114","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Dr\u00fceke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbr.2025.115465_bib115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib116","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/13803390490514875","article-title":"The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function","volume":"26","author":"Awad","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.bbr.2025.115465_bib117","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.ajkd.2009.12.038","article-title":"Alberta Kidney Disease Network, Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis","volume":"55","author":"Shurraw","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib118","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.2215\/CJN.02680314","article-title":"Intradialytic hypotension and risk of cardiovascular disease","volume":"9","author":"Stef\u00e1nsson","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbr.2025.115465_bib119","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib120","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib121","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69795","article-title":"A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons","volume":"10","author":"Kim","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.bbr.2025.115465_bib122","article-title":"Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition","volume":"12","author":"D","year":"2001","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.bbr.2025.115465_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1137197","article-title":"Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer\u2019s disease: a nationwide population-based cohort study","volume":"15","author":"Lee","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbr.2025.115465_bib124","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/molecules29040747","article-title":"Neuropsychiatric systemic lupus erythematosus: molecules involved in its imunopathogenesis, clinical features, and treatment","volume":"29","author":"Justiz-Vaillant","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2025.115465_bib125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2024.06.024","article-title":"Prevalence of anxiety, depression, sleeping problems, cognitive impairment, and suicidal ideation in people with autoimmune skin diseases","volume":"176","author":"Jia","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbr.2025.115465_bib126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2021.1995860","article-title":"The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease","volume":"55","author":"Kong","year":"2022","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbr.2025.115465_bib127","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbr.2025.115465_bib128","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2018.12.004","article-title":"Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus","volume":"18","author":"Duarte-Delgado","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbr.2025.115465_bib129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/biom11020310","article-title":"Organ fibrosis and autoimmunity: the role of inflammation in TGF\u03b2-dependent EMT","volume":"11","author":"Sisto","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbr.2025.115465_bib130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.autrev.2018.12.004","article-title":"Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus","volume":"18","author":"Duarte-Delgado","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbr.2025.115465_bib131","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0961203318820707","article-title":"Angiotensin II type 2 receptor gene polymorphisms and serum angiotensin-converting enzyme level in Egyptian children with systemic lupus erythematosus","volume":"28","author":"Shoaib","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.bbr.2025.115465_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01572","article-title":"Targeting the protective arm of the renin-angiotensin system to reduce systemic lupus erythematosus related pathologies in MRL-lpr mice","volume":"11","author":"Soto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbr.2025.115465_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105874","article-title":"The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapies","volume":"180","author":"Zima","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2025.115465_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105874","article-title":"The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapies","volume":"180","author":"Zima","year":"2024","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2025.115465_bib135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbr.2025.115465_bib136","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/jcbfm.2009.262","article-title":"Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-\/- mice","volume":"30","author":"Semple","year":"2010","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.bbr.2025.115465_bib137","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s13311-023-01435-8","article-title":"The renin angiotensin system as a therapeutic target in traumatic brain injury","volume":"20","author":"Villapol","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2025.115465_bib138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer\u2019s disease: clinical practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib139","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","article-title":"Glial-neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u201ccytokine cycle\u201d in disease progression","volume":"8","author":"Griffin","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbr.2025.115465_bib140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2025.115465_bib141","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/BF00571510","article-title":"Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer\u2019s disease patients","volume":"89","author":"Huell","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2025.115465_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01349-z","article-title":"Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"Lyra e Silva","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbr.2025.115465_bib143","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/87945","article-title":"TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice","volume":"7","author":"Wyss-Coray","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbr.2025.115465_bib144","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-\u03b2 signaling promotes neurodegeneration and Alzheimer\u2019s pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bbr.2025.115465_bib145","article-title":"Plasma MCP-1 and cognitive decline in patients with Alzheimer\u2019s disease and mild cognitive impairment: a two-year follow-up study","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2025.115465_bib146","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0197-4580(00)00259-1","article-title":"Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer\u2019s dementia","volume":"22","author":"Savaskan","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2025.115465_bib147","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2014.12.007","article-title":"Ang-(1-7) exerts protective role in blood-brain barrier damage by the balance of TIMP-1\/MMP-9","volume":"748","author":"Wu","year":"2015","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.bbr.2025.115465_bib148","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ncl.2024.05.006","article-title":"Neuropsychology and vascular cognitive impairment and dementia","volume":"42","author":"Cavanagh","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.bbr.2025.115465_bib149","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cells10040855","article-title":"IL-1\u03b2 antibody protects brain from neuropathology of hypoperfusion","volume":"10","author":"Quintana","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2025.115465_bib150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0404.2004.00286.x","article-title":"Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients","volume":"110","author":"Wada-Isoe","year":"2004","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbr.2025.115465_bib151","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000329568","article-title":"Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias","volume":"9","author":"Helmy","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib152","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11357-022-00556-w","article-title":"Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis","volume":"44","author":"Custodero","year":"2022","journal-title":"GeroScience"},{"key":"10.1016\/j.bbr.2025.115465_bib153","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-143102","article-title":"Genetics of vascular dementia: systematic review and meta-analysis","volume":"46","author":"Sun","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2025.115465_bib154","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/STROKEAHA.117.017370","article-title":"Brain transforming growth factor-\u03b2 resists hypertension via regulating microglial activation","volume":"48","author":"Li","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2025.115465_bib155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/ATVBAHA.111.236349","article-title":"Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells","volume":"32","author":"Song","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbr.2025.115465_bib156","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13251","article-title":"Dysregulation of the renin-angiotensin system in vascular dementia","volume":"34","author":"Tayler","year":"2024","journal-title":"Brain Pathol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T08:48:35Z","timestamp":1740473315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432825000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":156,"alternative-id":["S0166432825000518"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115465","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation in kidney disease and dialysis","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115465"}}